-
Je něco špatně v tomto záznamu ?
Association of serum adipocyte fatty acid-binding protein and apolipoprotein B /apolipoprotein A1 ratio with intima media thickness of common carotid artery in dyslipidemic patients
J. Orsag, D. Karasek, M. Halenka, H. Vaverkova, J. Spurna, V. Kubickova, J. Lukes, J. Zadrazil
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
30209438
DOI
10.5507/bp.2018.043
Knihovny.cz E-zdroje
- MeSH
- apolipoprotein A-I krev MeSH
- apolipoprotein B-100 krev MeSH
- arteria carotis communis diagnostické zobrazování MeSH
- ateroskleróza krev diagnostické zobrazování MeSH
- dospělí MeSH
- dyslipidemie krev diagnostické zobrazování MeSH
- intimomediální šíře tepenné stěny MeSH
- inzulinová rezistence MeSH
- lidé středního věku MeSH
- lidé MeSH
- metabolický syndrom krev diagnostické zobrazování MeSH
- nemoci arterie carotis krev diagnostické zobrazování MeSH
- proteiny vázající mastné kyseliny krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Diseases caused by atherosclerosis play the most important role in mortality and morbidity worldwide. Serum adipocyte fatty acid binding protein (A-FABP) seems to be a new promising marker to determine the risk of atherosclerosis. OBJECTIVE: The aim of this study was to evaluate relationships between serum A-FABP levels in studied individuals and to assess the possibility of modeling the intima media thickness of the common carotid artery (C-IMT) using A-FABP levels and other observed characteristics. METHODS: Seventy two Caucasian individuals were enrolled and divided into 3 groups: dyslipidemic patients with or without metabolic syndrome (MetS+, n=17; MetS-, n= 34) and controls (n=21). RESULTS: There was confirmed the well-established risk profile of individuals with MetS (unfavorable lipid and lipoprotein profile, as well as increased parameters of insulin resistence and C-IMT). A-FABP concentrations in this group were significantly higher in comparison with both MetS- and controls. CONCLUSION: Using multiple linear regression models of C-IMT values for all individual data, healthy controls and dyslipidemic patients without metabolic syndrome (MetS-) A-FABP levels were not revealed as an important predictor of C-IMT in our model. In contrast, age, gender, waist circumference, nonHDL cholesterol levels and ApoB/ApoA1 ratio were important repressors of C- IMT in study individuals. This finding may be attributed to the overwhelming effect of other more robust risk factors for atherosclerosis in these individuals.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028265
- 003
- CZ-PrNML
- 005
- 20220104150635.0
- 007
- ta
- 008
- 211105s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2018.043 $2 doi
- 035 __
- $a (PubMed)30209438
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Orság, Jiří $7 xx0229430 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 245 10
- $a Association of serum adipocyte fatty acid-binding protein and apolipoprotein B /apolipoprotein A1 ratio with intima media thickness of common carotid artery in dyslipidemic patients / $c J. Orsag, D. Karasek, M. Halenka, H. Vaverkova, J. Spurna, V. Kubickova, J. Lukes, J. Zadrazil
- 504 __
- $a Literatura
- 520 9_
- $a BACKGROUND: Diseases caused by atherosclerosis play the most important role in mortality and morbidity worldwide. Serum adipocyte fatty acid binding protein (A-FABP) seems to be a new promising marker to determine the risk of atherosclerosis. OBJECTIVE: The aim of this study was to evaluate relationships between serum A-FABP levels in studied individuals and to assess the possibility of modeling the intima media thickness of the common carotid artery (C-IMT) using A-FABP levels and other observed characteristics. METHODS: Seventy two Caucasian individuals were enrolled and divided into 3 groups: dyslipidemic patients with or without metabolic syndrome (MetS+, n=17; MetS-, n= 34) and controls (n=21). RESULTS: There was confirmed the well-established risk profile of individuals with MetS (unfavorable lipid and lipoprotein profile, as well as increased parameters of insulin resistence and C-IMT). A-FABP concentrations in this group were significantly higher in comparison with both MetS- and controls. CONCLUSION: Using multiple linear regression models of C-IMT values for all individual data, healthy controls and dyslipidemic patients without metabolic syndrome (MetS-) A-FABP levels were not revealed as an important predictor of C-IMT in our model. In contrast, age, gender, waist circumference, nonHDL cholesterol levels and ApoB/ApoA1 ratio were important repressors of C- IMT in study individuals. This finding may be attributed to the overwhelming effect of other more robust risk factors for atherosclerosis in these individuals.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a apolipoprotein A-I $x krev $7 D016632
- 650 _2
- $a apolipoprotein B-100 $x krev $7 D053299
- 650 _2
- $a ateroskleróza $x krev $x diagnostické zobrazování $7 D050197
- 650 _2
- $a nemoci arterie carotis $x krev $x diagnostické zobrazování $7 D002340
- 650 _2
- $a arteria carotis communis $x diagnostické zobrazování $7 D017536
- 650 _2
- $a intimomediální šíře tepenné stěny $7 D059168
- 650 _2
- $a dyslipidemie $x krev $x diagnostické zobrazování $7 D050171
- 650 _2
- $a proteiny vázající mastné kyseliny $x krev $7 D050556
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolický syndrom $x krev $x diagnostické zobrazování $7 D024821
- 650 _2
- $a lidé středního věku $7 D008875
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Karásek, David $7 stk2007415300 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Halenka, Milan $7 xx0047393 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Vaverková, Helena, $d 1942- $7 nlk20000083882 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Spurná, Jaromíra $7 xx0227678 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Kubíčková, Veronika $7 xx0225011 $u Department of Clinical Biochemistry, University Hospital Olomouc, Czech Republic Corresponding author: Jiri Orsag, e-mail
- 700 1_
- $a Lukeš, Jiří $7 xx0070976 $u Department of Clinical Biochemistry, University Hospital Olomouc, Czech Republic
- 700 1_
- $a Zadražil, Josef, $d 1954- $7 xx0074493 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 163, č. 2 (2019), s. 166-171
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30209438 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20220104150630 $b ABA008
- 999 __
- $a ok $b bmc $g 1742226 $s 1148810
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 163 $c 2 $d 166-171 $e 20180911 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20211105